Super Pill No.4

product on market Capsule Ron Teeguarden's Dragon Herbs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile includes Nicotinamide Riboside and Astragaloside IV, which are researched for cellular energy and immune support. Other components like Tanshinone IIA and Lycium barbarum polysaccharides have limited to moderate evidence for cardiovascular and antioxidant effects. Overall, the clinical evidence coverage for this specific combination of ingredients is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Super Pill No.4
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
20
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 300.0mg (26 products) 7 studies (A:0, B:1)
Tanshinone IIA
112.5 mg
Gypenoside
180 mg
Lycium barbarum Polysaccharide
90 mg
Astragaloside IV
112.5 mg
Market median: 500.0mg (82 products) 19 studies (A:1, B:6)
Gynostemma pentaphyllum Extract, Powder, Pure
45 mg
Lycium barbarum Extract, Powder, Pure
135 mg
Market median: 470.0mg (230 products) 9 studies (A:3, B:3)

Other Ingredients

Pullulan, Natural Rice, Powder Bamboo Extract, Powder Rice Extract Blend
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 1-3 capsules once per day or as directed by a health care professional.

Warnings & Precautions

Consult your physician before using this product if you are on medication for any health condition.

Keep out of the reach of children.

Formulation Notes

Cutting edge nutraceutical Jing & Qi formulation Super Pill No.4 is a nutraceutical Jing-Qi adaptogenic formulation, composed of 5 superior quality, cutting edge nutraceutical ingredients - Nicotinamide Riboside (NR) to support NAD+ production and sirtuin functionality, Tanshinone IIA to support cardiovascular health, Astragaloside IV to support the immune system, Gypenosides to help modulate nuclear factor kappa B (NF-kB), and Lycium barbarum polysaccharides (LBP) to support healthy aging.

Advanced nutraceutical healthy aging formulation

Pullulan caps - 100% natural, water-soluble polysaccharide from tapioca produced through a fermentation process; non-GMO; no starch, preservatives or chemical modifications; gluten free.

Pullulan caps - 100% natural, water-soluble polysaccharide from tapioca produced through a fermentation process; non-GMO; no starch, preservatives or chemical modifications; gluten free.

Additional Information

Super Pill No.4 400 mg each

Designed by Ron Teeguarden

Metadata

Product Details

UPC / SKU6 79372 00108 5
DSLD Entry Date2023-04-21
Product TypeOther Combinations
FormCapsule
DSLD ID279252
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
49
Avg Quality
8
Rct
1
Systematic Review
1
Clinical Trial
B Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Rct Nature communications 2018 PubMed DOI
C The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials
Systematic Review Frontiers in nutrition 2023 PubMed DOI
C Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.
Rct Nature aging PubMed DOI
C Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Rct Scientific reports 2019 PubMed DOI
C Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Rct Cell reports 2019 PubMed DOI
C Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
Rct Aging cell 2023 PubMed DOI
C Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
Rct BMC nephrology 2020 PubMed DOI
C Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
Clinical Trial ClinicalTrials.gov 2021
C A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals.
Rct JCI insight PubMed DOI
C Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial.
Rct Aging cell PubMed DOI
View all evidence for Nicotinamide Riboside →
Compare

Similar Products

View all Nicotinamide Riboside products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.